ELMSFORD, N.Y., Nov. 6, 2013 /PRNewswire/ -- BioScrip(R) , Inc. (NASDAQ: BIOS) today announced 2013 third quarter financial results. Third quarter revenue from continuing operations was $208.9 million and the net loss from continuing operations was $22.4 million, or a loss of $0.35 per diluted share. Consolidated Adjusted EBITDA for the third quarter was $12.1 million, and consolidated adjusted earnings per diluted share for the third quarter was $0.00 per diluted share.
Help employers find you! Check out all the jobs and post your resume.
